Karen S. McCoy, MD

Karen S. McCoy, MD, is Chief of the Section of Pulmonary Medicine at Nationwide Children’s Hospital and Chief of the Division of Pediatric Pulmonology and an Associate Professor of Pediatrics at The Ohio State University College of Medicine. Her clinical interests focus on managing patients of all ages with cystic fibrosis (CF) and pediatric asthma. Dr. McCoy’s research interests revolve around clinical outcomes and trials in cystic fibrosis and asthma. She is the principal investigator for the CF Translational Therapeutic Development Center and the Asthma Clinical Research Center. She is the Director of the CF Center, Associate Director of the fellowship-training program in pediatric pulmonology, Medical Director for Infant and Non-infant Pulmonary Function, Respiratory Care and the CF Newborn Screening Program.

Gender:

• Female

Languages Spoken:

• English

Research Center:

• Hospital-Based Research Faculty

Research Funding*:

• Cystic Fibrosis Center, Cystic Fibrosis Foundation
• CF Therapeutic Development Network, Cystic Fibrosis Foundation
• Mild CF Lung Disease Treatment Study, Anonymous
• Asthma Clinical Research Center, Ohio State University Research Foundation/American Lung Association
• The Study of Acid Reflux in Children with Asthma, Ohio State University Research Foundation/American Lung Association

Fellowship

• Arizona Health Sciences Center

Fellowship

• Arizona Health Sciences Center

Internship

• North Carolina Memorial Hospital

Residency

• North Carolina Memorial Hospital

Medical School

• University of North Carolina School of Medicine

Residency

• North Carolina Memorial Hospital

Medical School

• University of North Carolina
  Date Completed: 06/30/1975

Internship

• North Carolina Memorial Hospital
  Date Completed: 06/30/1977

Residency

• North Carolina Memorial Hospital
  Date Completed: 06/30/1979

Fellowship

• Arizona Health Science Center
  Date Completed: 06/30/1982

Department:

• Pediatrics

Section:

• Pulmonary Medicine

Speciality:

• Pediatric Pulmonary Medicine
  
• Pediatrics
  

Date of Appointment at Nationwide Children’s Hospital:

• 02/16/1988

1995–present

• Associate Prof Pediatrics, Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children's Hospital, Columbus, OH

1987–1995

• Asst. Prof Pediatrics, Division of Pulmonary Medicine, OSU College of Medicine and Chief, Section of Pulmonary Medicine, and Director, Cystic Fibrosis Center, Nationwide Children's Hospital, Columbus, OH

1985–1987

• Asst. Prof Pediatrics, Division of Pulmonary Disease/Cystic Fibrosis Regional Center, University of Florida College of Medicine, Gainesville, Fl

1982–1984

• Asst. Prof Pediatrics, OSU College of Medicine and Medical Director of Respiratory Care and Pulmonary Functions, Children's Hospital, Columbus, OH

1979–1982

• Fellowship Ped. Pulmonary Disease Arizona Health Science Center Tucson, AZ

1977–1979

• Residency Pediatrics NC Memorial Hospital, Chapel Hill, NC

1976–1977

• Internship Pediatrics NC Memorial Hospital, Chapel Hill, NC

• Sheikh, S, Ryan-Wenger, NA, McCoy, KS. 2012. Outcomes of Surgical Management of Severe GERD in Patients with Cystic Fibrosis.  Pediatric Pulmonology. Vol. 22630, no. September: e0.
• Kopp,Benjamin,T; Abdulrahman,Basant,A; Khweek,Arwa,A; Kumar,Surender,B; Akhter,Anwari; Montione,Richard; Tazi,Mia,F; Caution,Kyle; McCoy,Karen; Amer,Amal,O. 2012. Exaggerated inflammatory responses mediated by Burkholderia cenocepacia in human macrophages derived from Cystic fibrosis patients.  BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Vol. 424, no. 2. (July): 221-227.
• Kopp BT; Wang W; Chisolm DJ; Kelleher KJ; McCoy KS. 2012. Inpatient healthcare trends among adult cystic fibrosis patients in the U.S.  Pediatric Pulmonology. Vol. 47, no. March: e245.
• Clancy JP; Rowe SM; Accurso FJ; Aitken ML; Amin RS; Ashlock MA; Ballmann M; Boyle MP; Bronsvelt I; Campbell PW; DeBoeck K; Donaldson SH; Dorkin HL; Dunitz JM; Durie PR; Jain M; Leonard A; McCoy KS; Moss RB; Pilewski JM; Rosenbluth DB; Rubenstein RC; Schechter MS; Botfield M; Ordonez CL; Spencer-Green GT; Vernillet L; Wisseh S; Yen K; Konstan MW. 2012. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.  Thorax. Vol. 67, no. January: e12.
• Chisolm DJ; Hardin DS; McCoy KS; Johnson LD; McAlearney AS; Gardner W. 2011. Health literacy and willingness to use online health information by teens with asthma and diabetes.  The Official Journal Of The American Telemedicine Association. Vol. 17, no. November: e676.
• Abdulrahman BA; Kwheek AA; Akhter A; Caution K; Kotrange S; Abdelaziz DH; Newland C; Rosales-Reyes R; Kopp B; McCoy K; Montione R; Schlesinger LS; Gavrilin MA; Wewers MD; Valvano MA; Amer AO. 2011. Autophagy stimulation by rapamycin suppresses lung inflammation and infection by Burkholderia cenocepacia in a model of cystic fibrosis.  Autophagy. Vol. 7, no. November: 1359-1370.
• Oermann CM; McCoy KS; Retsch-Bogart GZ; Gibson RL; McKevitt M; Montgomer AB. 2011. Pseudomonas aeruginosa antibiotic susceptibility during long-term use of aztreonam for inhalation solution (AZLI).  The Journal of Antibicrobial Chemotherapy. Vol. 66, no. October: e2398.
• 1: Kotrange S, Kopp B, Akhter A, Abdelaziz D, Abu Khweek A, Caution K,Abdulrahman B, Wewers MD, McCoy K, Marsh C, Loutet SA, Ortega X, Valvano MA, AmerAO. 2010. Burkholderia cenocepacia O polysaccharide chain contributes tocaspase-1-dependent IL-1beta production in macrophages.  J Leukoc Biol. 2011Mar;89(3):481-8. Epub 2010 Dec 22. PubMed PMID: 21178113; PubMed Central PMCID:PMC3040464..
• Oermann CM; Retsch-Bogart GZ; Quittner AL; Gibson RL; McCoy KS; Montgomery AB; Cooper PJ. 2010. An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosis.  Pediatric Pulmonology. Vol. 45, no. 11. (November): e1121.
• Retsch-Bogart GZ, Quittner A, Gibson RL, Oermann CM, McCoy KS, Montgomery AB, Cooper PJ. 2009. Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis.  Chest. Vol. 135, no. January: 1223-1232.
• McCoy KS, Quittner, AL, Oermann CM, Gibson RL, Retsch-Bogart GZ, Montgomery AB. 2008. Inhaled Aztreonam Lysine for Chronic Airway Pseudomonas aeruginosa in Cystic Fibrosis.  Am J Respiratory Crit Care Med. Vol. 178, no. 9. (November): 921-928.
• Retsch-Bogart GZ, Burns, JL, Otto, KL, Liou, TG, McCoy KS, Oermann CM, Gibson R. 2008. A Phase 2 Study of Aztreonam Lysine for Inhalation to Treat Patients With Cystic Fibrosis and Pseudomonas aeruginosa Infection.  Pediatr Pulmonol. Vol. 43, no. January: 47-58.
• Sheikh S, McCoy KS. 2008. Idiopathic Pulmonary Hemosiderosis. In Pediatric Respiratory Medicine. 2nd ed. Edited by LM Taussig LI Landau. Philadelphia, PA: Mosby Elsevier.
• Simon RH, McCoy KS, Retsch-Bogart GZ. 2007. Emerging Insights on the Future of Cystic Fibrosis Management: Improving Lung Function and Managing Infection. Old Lyme, CT: The France Foundation A Continuing Medial Education Company.
• McCoy K. 2007. Compounded Colistimethate as Possible Cause of Fatal Acute Respiratory Distress Syndrome.  New England Journal Medicine. Vol. 357, no. 22. (January): 2310-2311.
• McCoy K, Shade D, Irvin C, Mastronarde J, Hanania N, Castro M, Anthonisen NR, for the American Lung Association Asthma Clinical Research Centers. 2006. Predicting Episodes of Poor Asthma Control in Treated Patients with Asthma.  J Allergy Clin Immunol. Vol. 118, no. 6. (December): 1226-1233.
• Chisolm DJ, McAlearney AS, Veneris S, Fisher D, Holtzlander M, McCoy K. 2006. The Role of Computerized Order Sets in Pediatric Inpatient Asthma Treatment.  Pediatr Allergy Immunol. Vol. 17, no. 3. (May): 199-206.
• Best K, McCoy K, Gemma S, DiSilvestro RA. 2005. Copper Enzyme Activities in Cystic Fibrosis Before and After Copper Supplementation Plus or Minus Zinc.  Metabolism. Vol. 53, no. 1. (January): 37-41.
• Castile R, Iram D, McCoy K. 2004. Gas Trapping in Normal Infants and Infants with Cystic Fibrosis.  Pediatr Pulmonol. Vol. 37, no. January: 461-469.
• Ernst RK, D'Argenio DA, Ichikawa JK, Bangera MG, Selgrade S, Burns JL, Hiatt P, McCoy K, Brittnacher M, Kas A, Spencer DH, Olson MV, Ramsey BW, Lory S, Miller SI. 2003. Genome Mosaicism is Conserved But Not Unique in Pseudomonas aeruginosa Isolates from the Airways of Young Children with Cystic Fibrosis.  Environ Microbiol. Vol. 5, no. 12. (December): 1341-1349.
• Varekojis SM, Douce FH, Flucke RL, Filbrun DA, Tice JS, McCoy KS, Castile RG. 2003. A comparison of the therapeutic effectiveness and preference for postural drainage and percussion, intrapulmonary percussive ventilation and high frequency chest wall compression in hospitalized patients with cystic fibrosis.  Respir Care. Vol. 48, no. January: 24-28.
• Sheikh, S, Castile R, Hayes J, McCoy K, Eid NS. 2003. Assessing Bronchodilator Responsiveness in Infants Using Partial Expiratory Flow-Volume Curves.  Pediatr Pulmonol. Vol. 36, no. January: 196-201.
• Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P, McCoy K, McNamara S, Ramsey B, Wagener J. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28:321-328.
• Piedra P, Proveda G, Ramsey B, McCoy K, Hiatt P: Incidence and prevalence of neutralizing antibioties to the common adenoviruses in children with cystic fibrosis: Implication for gene therapy with adenovirus vectors. Pediatrics 101:1013-1019,1998.
• Iram D, Castile R, Filbrun D, Flucke R, McCoy K: Gas trapping in normal infants and in infants with cystic fibrosis. Pediatr Pulmonol 17:329, 1998
• Long FR, Castile RG, Brody AS, Hogan MJ, Flicke RL, Filbrun DA, McCoy KS: Lungs in infants and young children: improved thin-section CT with a noninvasive controlled-ventilation technique-initial experience. Radiology. Aug;212(2):588-93, 1999.
• Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW: Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis. The Journal of Infectious Disease 2001;183:444-52.
• McCoy K, Jones J, Johnson M, Allen E, Shell R. “The Safety of Inactivated Influenza Vaccine in Adults and Children with Asthma” -- ALA-ACRC sponsored study. N Engl J Med, Vol. 345, No. 21 – Nov. 2001.
• Zuckerman JB, Robinson CB, McCoy KS, Shell RD, Sferra TJ, Chirmule N, Magosin SA, Propert KJ, Borwn-Parr EC, Hughes JV, Tazelaar J, Baker C, Goldman MJ, Wilson JM: A Phase I Study of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to a Lung Segment of Individuals with Cystic Fibrosis. Human Gene Therapy 10:2973-2985, December 10, 1999.
• From the American Lung Association Asthma Clinical Research Centers. 2001. The Safety of Inactivated Influenza Vaccine in Adults and Children with Asthma.  N Engl J Med. Vol. 345, no. 21. (November): 1529-1536.
• Rosenfeld M, Gibson RL, McNamara S, Emerson J, McCoy K, Shell R, Borowitz D, Konstan M, Retsch-Bogart, G, Wilmott R, Burns JL, Vicini P, Ramsey BW. 2001. Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis.  J Pediatr. Vol. 139, no. January: 572-577.
• Sheikh S, Allen E, Shell R, Iram D, Castile R, McCoy K. 2001. Chronic Aspiration Without Gastroesophogeal Reflux as a Cause of Chronic Respiratory Symptoms in Neurologically Normal Healthy Infants.  Chest. Vol. 120, no. January: 1190-1195.
• Rosenfeld M, Gibson RL, McNamara S, Emerson J, Burns JL, Castile R, Hiatt P, McCoy K, Wilson C, Inglis A, Smith A, Ramsey BW. 2001. Early Pulmonary Infection, Inflammation and Clinical Outcomes in Infants with Cystic Fibrosis.  Pediatr Pulmonol. Vol. 32, no. January: 356-366.
• Goldstein AB, Castile RG, Filbrun DA, Flucke RL, McCoy KS, Tepper RS. 2001. Bronchodilator Responsiveness in Normal Infants and Young Children.  Am J Respir Crit Care Med. Vol. 164, no. January: 447-454.
• Sheikh S, Null D, Gentile D, Skoner D, McCoy K, Guthrie R. 2001. Urinary Leukotriene E4 Excretion in Premature Infants During First Month of Life.  Chest. Vol. 119, no. January: 1749-1754.
• Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. 2001. Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis.  The Journal of Infectious Disease. Vol. 183, no. January: 444-452.
• Shell R, Allen ED, Mutabagani K, Long F, Davis T, McCoy K, and Castile R. 2001. Compression of the Trachea by the Innominate Artery in a 2-Month-Old Child.  Pediatr Pulmonol. Vol. 31, no. January: 80-85.
• Shell R, McCoy K. 2000. A New Century of Hope for Cystic Fibrosis and Gene Therapy.  Pediatric Directions.
• Castile R, Filbrun D, Flucke R, Franklin W, McCoy K. 2000. Adult-type Pulmonary Function in Infants Without Respiratory Disease.  Pediatr Pulmonol. Vol. 30, no. January: 215-237.
• Zuckerman JB, Robinson CB, McCoy KS, Shell RD, Sferra TJ, Chirmule N, Magosin SA, Propert KJ, Borwn-Parr EC, Hughes JV, Tazelaar J, Baker C, Goldman MJ, Wilson JM. 1999. A Phase I Study of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to a Lung Segment of Individuals with Cystic Fibrosis.  Human Gene Therapy. Vol. 10, no. December: 2973-2985.
• Mutabagani KH, Menke JA, McCoy KS, Besner GE. 1999. Bronchopexy for Congenital Bronchomalacia in the Newborn.  J Pediatr Surg. Vol. 34, no. 8. (August): 1300-1303.
• Long FR, Castile RG, Brody AS, Hogan MJ, Flicke RL, Filbrun DA, McCoy KS. 1999. Lungs in Infants and Young Children: Improved Thin-Section CT with a Noninvasive Controlled-Ventilation Technique—Initial Experience.  Radiology. Vol. 212, no. 2. (August): 588-593.
• Kien CL, Horswill CA, Zipf WB, McCoy KS, Denne SC. 1999. Splanchnic Uptake of Leucine in Healthy Children and in Children with Cystic Fibrosis.  Pediatr Res. Vol. 45, no. May: 680-683.
• Rosenfeld M, Emerson J, Accurso F, Armstrong D, Castile R, Grimwood K, Hiatt P McCoy K, McNamara S, Ramsey B, Wagener J. 1999. Diagnostic Accuracy of Oropharyngeal Cultures in Infants and Young Children with Cystic Fibrosis.  Pediatr Pulmonol. Vol. 28, no. January: 321-328.
• McCoy KS. 1999. Hemosiderosis. In Pediatric Respiratory Medicine. Edited by LM Taussig, LI Landau, PN Le Souef, WJ Morgan, FD Martinez, and PD Sly. St. Louis, MO: Mosby Company.
• Hogan MJ, Coley BD, Shiels II WE, Allen ED, McCoy KS. 1998. Recurrent Deep Venous Thrombosis Complicating PICC Line Placement in Two Patients with Cystic Fibrosis and Activated Protein C-resistance.  Pediatr Radiol. Vol. 28, no. 7. (July): 552-553.
• Hogan MJ, Coley BD, Shiels WE, Allen ED, McCoy KS. 1998. Thrombotic Complications of the Peripheral Insertion of Central Catheters in Cystic Fibrosis Patients.  Pediatr Radiol. Vol. 28, no. January: 552-553.
• Castile R, Tice J, Flucke R, Filbrun D, Varekojis S, McCoy K. 1998. Comparison of three sputum clearance methods in in-patients with cystic fibrosis.  Pediatr Pulmonol. Vol. 17, no. January: e329.
• Bates RD, Nahata MC, Jones JW, McCoy KS, Young GA, Cox S, Barson WJ. 1997. Pharmacokinetics and Safety of Tobramycin After Once-daily Administration in Patients with Cystic Fibrosis.  Chest. Vol. 112, no. 5. (November): 1208-1213.
• Potter CJ, Fishbein M, Hammonds S, McCoy KS, Qualman S. 1997. Can the Histologic Changes of Cystic Fibrosis Associated Hepatobiliary Disease be Predicted by Clinical Criteria.  J Pediatr Gastroenterol Nutr. Vol. 25, no. 1. (July): 32-36.
• McCoy K, Stokes D, Dubroff M, Hoffman A, Mischler N, Erickson S. 1997. Managed Care and the Cystic Fibrosis Patient.  Current Opinion in Pulmonary Medicine. Vol. 3, no. January: 425-429.
• King DR, Patrick LE, Ginn-Pease ME, McCoy KS, Klopfenstein K. 1997. Pulmonary Function is Compromised in Children with Mediastinal Lymphoma.  J Pediatr Surg. Vol. 32, no. 2. (January): 294-299.
• Kien CL, Zipf WB, Horswill CA, Denne SC, McCoy KS, O’Dorisio TM. 1996. Effects of Feeding on Protein Turnover in Healthy Children and in Children with Cystic Fibrosis.  Am J Clin Nutr. Vol. 64, no. January: 608-614.
• McCoy KS, Hamilton S, Johnson C. 1996. Effects of 12-week Administration of Dornase Alfa in Advanced Cystic Fibrosis Lung DiseaseC.  Chest. Vol. 110, no. January: 889-895.
• Wilmott RW, Amin RS, Colin AA, DeVault A, Dozor AJ, Eigen H, Johnson C, Lester LA, McCoy KS, Kean LP, Moss R, Nash ML, Pagel Jue C, Regelmann W, Stokes DC, uchs HJ. 1996. Aerosolized Recombinant Human DNase in Hospitalized Cystic Fibrosis Patients with Acute Pulmonary Exacerbations.  Am J Resp Crit Care Med Jun. Vol. 153, no. 6 pt. 1. (January): 1914-1917.
• McCoy KS, Castile RG, Allen ED, Filbrun DA, Flucke RL, Bar-Yishay E. 1995. Functional Residual Capacity Measurements by Plethysmography and Helium Dilution in Normal Infants.  Pediatr Pulmonol. Vol. 19, no. January: 282-290.
• Allen ED, Mick AB, Nicol J, McCoy KS. 1995. Prolonged parenteral nutrition for cystic fibrosis patients.  Nutr Clin Pract. Vol. 10, no. 2. (January): 73-79.
• Kein CL, Horswill CA, Zipf WB, McCoy KS, O’Dorisio TM. 1995. Elevated Hepatic Glucose Production in Children with Cystic Fibrosis.  Pediatr Res. Vol. 34, no. 5. (January): 600-605.
• Fiel SB, Fuchs HJ, Johnson C, Gonda I, Clark AR, Cipolla CC, Colin A, Colombo J, Denning C, Dozor A, Eigen H, Eisenberg J, Fink R, Geller D, GerstleR, Glasser L, Green C, Hernried L, Johnson G, Jone K, Kaslovsky R, Kirchner K, Light M, Lloydstill JD, Maju. 1995. Comparison of 3 Jet Nebulizer Aerosol Delivery Systems Used To Administer Recombinant Human DNase-I to Patients with Cystic Fibrosi.  Chest. Vol. 1, no. 108. (January): 153-156.
• Davis JT, Ruberg RL, Leppink DM, McCoy KS, Wright C. 1995. Lateral Thoracic Expansion for Jeune’s Asphyxiating Dystrophy: A New Approach.  Ann Thorac Surg. Vol. 60, no. 3. (January): 694-696.
• Horswill CA, Kien CL, Zipf WB, McCoy KS. 1994. Feeding-induced Changes in Energy Expenditure in Children with Cystic Fibrosis.  Journal of Parenteral and Enteral Nutrition (JPEN). Vol. 18, no. January: 467-502.
• Allen ED, McCoy KS. 1994. Airway Disorders. In Perinatal and Pediatric Respiratory Care. Edited by S Barnhart, D Benham, and RH Warren. Orlando, FL: W.B. Saunders Company.
• Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl MD, member of the Pulmozyme Study Group McCoy KS. 1994. Effect of Aerosolized Recombinant Human Dnase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis.  N Engl J Med. Vol. 42, no. January: 337-342.
• McCoy KS, Grossman N. 1993. Venous thrombosis and pulmonary embolus in childhood. In Pediatric Respiratory Disease: Diagnosis and Treatment. Edited by BC Hilman. Orlando, FL: Grune & Stratton, Inc., W.B. Saunders Company.
• McCoy KS. 1993. Cystic Fibrosis: Medical Issues. In The Source Book of Pediatric Psychology. Edited by RA Olson, LL Mullins, JB Gillman, and JM Cheney. Needham Heights, MA: Allyn and Bacon, Inc..
• Landau LI, Morgan W, McCoy KS, Taussig LM. 1993. Gender Related Differences in Airway Tone in Children.  Pediatric Pulmonology. Vol. 16, no. January: 31-35.
• Allen ED, Pfaff JK, Taussig LM, McCoy KS. 1992. The clinical spectrum of chronic appendical abscess in cystic fibrosis.  AJDC. Vol. 146, no. January: 1190-1193.
• McCoy KS, Bagwell CE, Wagner M, Sallent J, O’Keefe M, Kosch PC. 1992. Spirometric and Endoscopic Evaluation of Airway Collapse in Infants with Bronchopulmonary Dysplasia (BPD).  Pediatr Pulmonol. Vol. 14, no. January: 23-27.
• Zipf WB, Kien CL, Horswill CA, McCoy KS, O’Doriso T, Pinyerd BL. 1991. Effects of Tolbutamide on Growth and Body Composition on Nondiabetic Children with Cystic Fibrosis.  Pediatric Research. Vol. 30, no. 4. (January): 309-314.
• Horswill, CA, Zipf, WB, Kein, CL, McCoy, KS, O’Dorisio, TM. 1990. Glipizide Increased Insulin Secretion but not Growth of Children with CF.  FASEB. Vol. 4, no. January: e3272A.
• Allen ED, McCoy KS. 1990. Presentation of Bronchial Mucoepidermoid Carcinoma as Unilateral Hyperlucent Lung.  Pediatr Pulmonol. Vol. 8, no. 4. (January): 294-297.
• Cromer BA, Enrile B, McCoy KS, Gerhardstein MJ, Fitzpatrick M, Judis J. 1990. Knowledge Attitudes, and Behavior Related to Sexuality in Adolescents with Chronic Disability.  Developmental Medicine and Child Neurology.
• McCoy KS. 1988. Pediatric Parenchymal Diseases. In Neonatal and Pediatric Respiratory Care. Edited by P Beck-Koff, DV Eitzman, J Neu. St. Louis, MO: C.V. Mosby Company.
• Mahaney MC, McCoy KS. 1986. Developmental Delays and Pulmonary Disease Severity in Cystic Fibrosis.  Hum Biol. Vol. 58, no. 3. (January): 445-460.
• Mahaney MC, McCoy KS. 1985. Functional Adaptation in Delayed Development of Children and Adolescents with Cystic Fibrosis.  Am J Phys Anthropol. Vol. 66, no. 2. (January): e201.
• Davis PB, Hubbard VS, McCoy KS, Taussig LM. 1983. Familial Bronchiectasis: Report of Three Kindreds and a Review of the Literature.  J Pediatr. Vol. 102, no. 2. (January): 177-185.
• McCoy KS, Koopman K, Taussig LM. 1981. Sleep-related Breathing Disorders.  Am J Otolaryngol. Vol. 2, no. 3. (January): 228-232.
• McCoy KS. 1981. Sudden Infant Death Syndrome.  Ariz med. Vol. 38, no. 6. (January): 432-435.
• Sheikh S; McCoy K. Nissen Fundoplication in Patients with Cystic Fibrosis.  Pediatric Pulmonology.
• McCoy K. Compounded Colistimethate as Possible Cause of Fatal Acute Respiratory Distress Syndrome. New England Journal of Medicine 357(22): 2310-1, November 29, 2007.

• Listed, Best Doctors in America